DK554988A - Hjertebeskyttende middel - Google Patents

Hjertebeskyttende middel

Info

Publication number
DK554988A
DK554988A DK554988A DK554988A DK554988A DK 554988 A DK554988 A DK 554988A DK 554988 A DK554988 A DK 554988A DK 554988 A DK554988 A DK 554988A DK 554988 A DK554988 A DK 554988A
Authority
DK
Denmark
Prior art keywords
protective agent
heart protective
heart
agent
protective
Prior art date
Application number
DK554988A
Other languages
English (en)
Other versions
DK554988D0 (da
Inventor
Takao Takaya
Hisashi Takasugi
Kimio Esumi
Atsushi Kuno
Hiroyoshi Sakai
Kazuhiro Maeda
Yoshie Sakamoto
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/184,195 external-priority patent/US4857527A/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of DK554988D0 publication Critical patent/DK554988D0/da
Priority claimed from HU885132A external-priority patent/HUT51614A/hu
Publication of DK554988A publication Critical patent/DK554988A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK554988A 1987-10-05 1988-10-04 Hjertebeskyttende middel DK554988A (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP25177187 1987-10-05
US07/184,195 US4857527A (en) 1985-12-12 1988-04-21 Morpholine containing pyridine compounds, compositions and use
HU885132A HUT51614A (en) 1985-12-12 1988-10-04 Process for producing cardio-protective and suitable for treating ischemic illnesses pharmaceutical compositions containing nitriferous heterocyclic compounds as active agent as well as for producing the active agents

Publications (2)

Publication Number Publication Date
DK554988D0 DK554988D0 (da) 1988-10-04
DK554988A true DK554988A (da) 1989-04-06

Family

ID=27270050

Family Applications (1)

Application Number Title Priority Date Filing Date
DK554988A DK554988A (da) 1987-10-05 1988-10-04 Hjertebeskyttende middel

Country Status (10)

Country Link
EP (1) EP0311322B1 (da)
JP (1) JPH01207234A (da)
CN (1) CN1041589A (da)
AU (1) AU621067B2 (da)
CA (1) CA1317296C (da)
DE (1) DE3882476T2 (da)
DK (1) DK554988A (da)
ES (1) ES2058301T3 (da)
FI (1) FI884418A (da)
NO (1) NO884399L (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8905526D0 (en) * 1989-03-10 1989-04-19 Fujisawa Pharmaceutical Co N-containing heterocyclic compounds,processes for the preparation thereof and composition comprising the same
GB2266841A (en) * 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
US6384058B1 (en) 1997-12-11 2002-05-07 American Home Products Corporation 2,4,6-trisubstituted pryridines with estrogenic activity and methods for the solid phase synthesis thereof
US6503917B1 (en) 1998-12-10 2003-01-07 Wyeth, Five Giralda Farms 2,4,6-trisubstituted pyridines with estrogenic activity and methods for the solid phase synthesis thereof
US20030153503A1 (en) * 2001-12-06 2003-08-14 Klaus Stephen J. Methods of increasing endogenous erythropoietin (EPO)
EP2295060B1 (en) * 2001-12-06 2018-10-31 Fibrogen, Inc. Treatment or prevention of ischemic or hypoxic conditions
CN101664408B (zh) * 2001-12-06 2013-05-01 法布罗根股份有限公司 低氧诱导因子(HIF)α的稳定化

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8530602D0 (en) * 1985-12-12 1986-01-22 Fujisawa Pharmaceutical Co Heterocyclic compounds

Also Published As

Publication number Publication date
DE3882476T2 (de) 1993-11-11
AU621067B2 (en) 1992-03-05
CN1041589A (zh) 1990-04-25
AU2333888A (en) 1989-06-01
EP0311322A3 (en) 1990-11-22
EP0311322A2 (en) 1989-04-12
ES2058301T3 (es) 1994-11-01
NO884399L (no) 1989-04-06
CA1317296C (en) 1993-05-04
FI884418A0 (fi) 1988-09-27
FI884418A (fi) 1989-04-06
EP0311322B1 (en) 1993-07-21
NO884399D0 (no) 1988-10-04
DK554988D0 (da) 1988-10-04
DE3882476D1 (de) 1993-08-26
JPH01207234A (ja) 1989-08-21

Similar Documents

Publication Publication Date Title
DK164688D0 (da) Huderstatning
FR2617721B1 (fr) Catheter
ES2021589B3 (es) Cateter
NO170911C (no) Rullestol
NO883059D0 (no) Mikrobicidisk middel.
DK437885A (da) Luftfriskende middel
DK164187D0 (da) Plaquemodvirkende oralt middel
KR900700442A (ko) 신규 부정맥 치료제 i
DK315088A (da) Plaquemodvirkende oralt middel
DK444288D0 (da) Humant reg - protein
DK554988D0 (da) Hjertebeskyttende middel
FR2619009B1 (fr) Agent anti-hyperlipemique
DK24285D0 (da) Fungicidt middel
DK646487D0 (da) Froedesinficerende middel
DK485088D0 (da) Antiviralt middel
AT388763B (de) Herzstueck
FR2616660B1 (fr) Agent antiepileptique
KR880015313U (ko) 수도전의 보호통
KR890012641U (ko) 의료용 장갑
FR2619636B1 (fr) Collimateur
ES1008460Y (es) Cateter
SE8701697D0 (sv) Kateter
DK598185D0 (da) Vandbloedgoerende middel
DK362687A (da) Desensibiliserende dentalt middel
KR890012708U (ko) 활동완구

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment